Ep. 243 – Dr. Richard Horowitz’s New Book on Ending Chronic Illness

Dr. Richard Horowitz reports the first published case of reversing P-tau 217, the most sensitive and specific Alzheimer's biomarker, in a live patient using a nine-week oral dapsone combination protocol, lowering it by 63% compared to the 23% reduction seen over six to seven years with anti-amyloid drugs like lecanemab. Author of the upcoming book Ending Chronic Illness, Dr. Horowitz breaks down his 16-point MSIDS model linking chronic Lyme disease, Bartonella, mold toxicity, and biofilm-persistent infections to Alzheimer's, long COVID, chronic fatigue syndrome, fibromyalgia, and autoimmune disease. He and Dr. Dean Mitchell also cover how to take a proper differential diagnosis history, why dapsone blocks the NLRP3 inflammasome pathway driving brain inflammation, and practical tick-bite prevention with picaridin and permethrin-treated clothing.

Social Media:
LinkedIn: linkedin.com/in/richard-horowitz-b4634012
Facebook: facebook.com/drrichardhorowitz
Instagram: @drrichardhorowitz

Websites:
Book (Ending Chronic Illness): cangetbetter.com/ending-chronic-illness
Primary site: cangetbetter.com

Resources / Book Links:
Medical Detective Substack: medicaldetective.substack.com
Dapsone documentary (2024): DrTalks: Discover Healing 18 - Dapsone Testimonials

Contact Dr. Mitchell:

Email: care@mitchellmedicalgroup.com
Website
Instagram
YouTube
Facebook
LinkedIn

Book: Conquering Candida
ImmunoLytics - code SmartestDoc, 5% off
Apollo Neuro - code SMARTMD